Please login to the form below

Eklira

This page shows the latest Eklira news and features for those working in and with pharma, biotech and healthcare.

AZ adds to respiratory portfolio with Actavis drugs

It follows a similar deal agreed in July last year for AZ to buy the global respiratory portfolio of Almirall for $2bn, including the approved Eklira (aclidinium) for COPD and several

Latest news

AstraZeneca signs $2bn deal to buy Almirall respiratory portfolio

Almirall's franchise includes Eklira (aclidinium), LAS40464 (a combination of aclidinium with formoterol, which has been filed in Europe), LAS100977 (abediterol), a once-daily phase II long-acting beta2-agonist (LABA),
Almirall expands in US via $400m deal to buy Aqua

under 22m on the back of high roll-out costs for new products such as Sativex (nabiximols) for spasticity in multiple sclerosis (MS) and chronic obstructive pulmonary disorder (COPD) treatment Eklira
IQWiG knocks back Almirall's Eklira

A long-acting bronchodilator, Eklira is licensed to treat adults with chronic-obstructive pulmonary disease (COPD) and works by widening their narrowed airways. ... The cost effectiveness body was similarly scathing when it came to making indirect
Breathing easier

While there are several therapies currently in late-stage clinical trials for COPD — including aclidinium bromide (Eklira, Almirall Prodesfarma/Forest Laboratories), vilanterol/fluticasone furoate (Relovair, GSK), andolast (Rottapharm Madaus) and
Almirall posts positive results

Potential key growth drivers ahead include the Eklira franchise, linaclotide, which offers a pan-European first-in-class opportunity in late stage development, Sativex for which approval is expected in Q2,

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Deal Watch table for November 2014

Eklira and Duaklir. Business unit acquisition. 3, 075. Pfizer / Merck KGaA.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior External Communications Lead: £Competitive Salary

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Account Director, Medical Education: Salary TBC

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Account Director: £Competitive Salary

Account director: Competitive salary and bonus scheme

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Account Manager: £Competitive Salary

Account Director, Healthcare Communications: Salary TBC

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Senior Medical Writer, MedComms Agency: Salary TBC

Experienced medical editor: Competitive salary and bonus scheme

Account Manager (PR): Great Benefits

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Publications director: Competitive salary and bonus scheme

Subscribe to our email news alerts

PMHub

Add my company

Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’: Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019: OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...